NCT Number: NCT00303173
The Relaxation and Blood Pressure in Pregnancy (REBIP) Study
Over 10% of women have high blood pressure during their pregnancy which may affect their health or that of their baby. There are currently no methods to prevent most high blood pressure in pregnancy and some treatments are not desirable for use in pregnancy. Previous research indicates that simple relaxation methods can reduce blood pressure and anxiety levels for some people, but this has not been well-studied, especially during pregnancy. This pilot study is intended to determine how guided imagery (imagining relaxing scenes) affects blood pressure and anxiety, and to assess how satisfied women are with this technique. Sixty-six pregnant women with high blood pressure will be randomly assigned to (1) listen to a guided imagery audio-compact disc or (2) quiet rest, at least twice-daily for 4 weeks. All women in both groups will receive all usual care, plus will have their blood pressure measured regularly during 1 day per week for 4 weeks. This study will determine if imagery lowers maternal blood pressure, and if further research on imagery effects on pregnancy health outcomes is feasible.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
Primary location
Womens Health Centre, Eastern Health, St. John's, Newfoundland and Labrador, Canada
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Pregnant, and less than or equal to (<) 36 weeks, 6 days gestation
- At least two prenatal blood pressure readings > 90 mmHg diastolic
- Has had clinical investigation of the hypertension
- Hearing acuity adequate to hear verbal and audiotaped instructions
- Planning to give birth at one of the study site health centres
- Competent to give informed consent
Exclusion criteria
- Likely to deliver within 10 days (including women with diastolic BP >110 mmHg, or systolic BP >170 mmHg; unstable diabetes, concurrent antepartum hemorrhage, preterm labour, and/or other significant medical)
- Prescribed antihypertensive medication at baseline
- Documented psychotic illness
- Unable to understand and read English
Treatment and study plan
Primary outcomes
-
Daytime ambulatory mean arterial pressure
Time frame: 4 weeks post-randomization (or if delivery is sooner, at most recent ambulatory BP monitoring session
Secondary outcomes
-
Daytime ambulatory systolic and diastolic blood pressure, and heart rate
Time frame: 4 weeks post-randomization (or if delivery is sooner, at most recent ambulatory BP monitoring session
-
Antihypertensive medication use after randomization
Time frame: between randomization and end of postpartum hospitalization
-
Maternal anxiety
Time frame: 4 weeks post-randomization (or if delivery is sooner, at most recent week of available data.
-
Time to delivery
-
Relationship of blood pressure changes to reported frequency of guided imagery undertaken
-
Relationship between classification of hypertension and effectiveness of guided imagery
-
Relationship between participants' evaluations of their imagery experiences and effectiveness of guided imagery
Time frame: At 4 weeks post-randomization (or if delivery is sooner, at most recent week od available data)
Sponsors and collaborators
Lead sponsor
University of Toronto
Other
Collaborators
- AWHONN Canada, with Canadian Nurses Foundation Nursing Care Partnership
- Dalhousie University
- IWK Health Centre with Canadian Nurses Foundation Nursing Care Partnership
Registry information
Official study title
A Randomized Controlled Trial of The Effectiveness of Guided Imagery on Blood Pressure in Hypertensive Pregnant Women: The Relaxation and Blood Pressure in Pregnancy (REBIP) Pilot Study
Important dates
- Study start
- 2004
- Primary completion
- 2006
- Study completion
- 2007
- First posted
- Mar 15, 2006
- Registry last updated
- Jun 25, 2008
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Blood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of Hypertension
NCT03334149
Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications
Aylesbury, United Kingdom
View Trial DetailsEliminating Severe Maternal Morbidity With Heart Health Doulas Trial
NCT05655936
Body Weight, Cardiovascular Diseases
Pittsburgh, Pennsylvania, United States
View Trial DetailsOptimal Blood Pressure Treatment Thresholds Postpartum
NCT06069102
Cardiovascular Diseases, Eclampsia
Pittsburgh, Pennsylvania, United States
View Trial DetailsSMART Health Pregnancy 2 - Intervention to Reduce Anaemia and Cardiometabolic Risk During Pregnancy and in the First Year Following Birth
NCT05752955
Anemia, Anemia of Pregnancy
Hyderabad, Telangana, India
View Trial Details